Possible leap ahead in filovirus therapeutics

Darryl Falzarano1, Heinz Feldmann1

  • 1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.

Cell Research
|April 16, 2014
PubMed
Summary

A new synthetic adenosine analogue, BCX4430, offers protection against Ebola and Marburg virus infections in animal models. This drug-like small molecule represents a potential therapeutic for filovirus diseases.